n-3 PUFA and obesity: from peripheral tissues to the central nervous system

Aline Haas de Mello, Marcela Fornari Uberti, Bianca Xavier de Farias, Nathalia Alberti Ribas de Souza, Gislaine Tezza Rezin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The current paradigms of prevention and treatment are unable to curb obesity rates, which indicates the need to explore alternative therapeutic approaches. Obesity leads to several damages to the body and is an important risk factor for a number of other chronic diseases. Furthermore, despite the first alterations in obesity being observed and reported in peripheral tissues, studies indicate that obesity can also cause brain damage. Obesity leads to a chronic low-grade inflammatory state, and the therapeutic manipulation of inflammation can be explored. In this context, the use of n-3 PUFA (especially in the form of fish oil, rich in EPA and DHA) may be an interesting strategy, as this substance is known by its anti-inflammatory effect and numerous benefits to the body, such as reduction of TAG, cardiac arrhythmias, blood pressure and platelet aggregation, and has shown potential to help treat obesity. Thereby, the aim of this narrative review was to summarise the literature related to n-3 PUFA use in obesity treatment. First, the review provides a brief description of the obesity pathophysiology, including alterations that occur in peripheral tissues and at the central nervous system. In the sequence, we describe what are n-3 PUFA, their sources and their general effects. Finally, we explore the main topic linking obesity and n-3 PUFA. Animal and human studies were included and alterations on the whole organism were described (peripheral tissues and brain).

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalBritish Journal of Nutrition
DOIs
StateAccepted/In press - Mar 27 2018
Externally publishedYes

Fingerprint

Omega-3 Fatty Acids
Central Nervous System
Obesity
Fish Oils
Brain
Platelet Aggregation
Cardiac Arrhythmias
Chronic Disease
Anti-Inflammatory Agents
Blood Platelets
Blood Pressure
Inflammation
Therapeutics

Keywords

  • Brain
  • Inflammation
  • n-3 PUFA
  • Obesity

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

n-3 PUFA and obesity : from peripheral tissues to the central nervous system. / Haas de Mello, Aline; Uberti, Marcela Fornari; de Farias, Bianca Xavier; de Souza, Nathalia Alberti Ribas; Rezin, Gislaine Tezza.

In: British Journal of Nutrition, 27.03.2018, p. 1-12.

Research output: Contribution to journalArticle

Haas de Mello, Aline ; Uberti, Marcela Fornari ; de Farias, Bianca Xavier ; de Souza, Nathalia Alberti Ribas ; Rezin, Gislaine Tezza. / n-3 PUFA and obesity : from peripheral tissues to the central nervous system. In: British Journal of Nutrition. 2018 ; pp. 1-12.
@article{fb8ce569a37e4f939cf3e329a5c3c114,
title = "n-3 PUFA and obesity: from peripheral tissues to the central nervous system",
abstract = "The current paradigms of prevention and treatment are unable to curb obesity rates, which indicates the need to explore alternative therapeutic approaches. Obesity leads to several damages to the body and is an important risk factor for a number of other chronic diseases. Furthermore, despite the first alterations in obesity being observed and reported in peripheral tissues, studies indicate that obesity can also cause brain damage. Obesity leads to a chronic low-grade inflammatory state, and the therapeutic manipulation of inflammation can be explored. In this context, the use of n-3 PUFA (especially in the form of fish oil, rich in EPA and DHA) may be an interesting strategy, as this substance is known by its anti-inflammatory effect and numerous benefits to the body, such as reduction of TAG, cardiac arrhythmias, blood pressure and platelet aggregation, and has shown potential to help treat obesity. Thereby, the aim of this narrative review was to summarise the literature related to n-3 PUFA use in obesity treatment. First, the review provides a brief description of the obesity pathophysiology, including alterations that occur in peripheral tissues and at the central nervous system. In the sequence, we describe what are n-3 PUFA, their sources and their general effects. Finally, we explore the main topic linking obesity and n-3 PUFA. Animal and human studies were included and alterations on the whole organism were described (peripheral tissues and brain).",
keywords = "Brain, Inflammation, n-3 PUFA, Obesity",
author = "{Haas de Mello}, Aline and Uberti, {Marcela Fornari} and {de Farias}, {Bianca Xavier} and {de Souza}, {Nathalia Alberti Ribas} and Rezin, {Gislaine Tezza}",
year = "2018",
month = "3",
day = "27",
doi = "10.1017/S0007114518000429",
language = "English (US)",
pages = "1--12",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",

}

TY - JOUR

T1 - n-3 PUFA and obesity

T2 - from peripheral tissues to the central nervous system

AU - Haas de Mello, Aline

AU - Uberti, Marcela Fornari

AU - de Farias, Bianca Xavier

AU - de Souza, Nathalia Alberti Ribas

AU - Rezin, Gislaine Tezza

PY - 2018/3/27

Y1 - 2018/3/27

N2 - The current paradigms of prevention and treatment are unable to curb obesity rates, which indicates the need to explore alternative therapeutic approaches. Obesity leads to several damages to the body and is an important risk factor for a number of other chronic diseases. Furthermore, despite the first alterations in obesity being observed and reported in peripheral tissues, studies indicate that obesity can also cause brain damage. Obesity leads to a chronic low-grade inflammatory state, and the therapeutic manipulation of inflammation can be explored. In this context, the use of n-3 PUFA (especially in the form of fish oil, rich in EPA and DHA) may be an interesting strategy, as this substance is known by its anti-inflammatory effect and numerous benefits to the body, such as reduction of TAG, cardiac arrhythmias, blood pressure and platelet aggregation, and has shown potential to help treat obesity. Thereby, the aim of this narrative review was to summarise the literature related to n-3 PUFA use in obesity treatment. First, the review provides a brief description of the obesity pathophysiology, including alterations that occur in peripheral tissues and at the central nervous system. In the sequence, we describe what are n-3 PUFA, their sources and their general effects. Finally, we explore the main topic linking obesity and n-3 PUFA. Animal and human studies were included and alterations on the whole organism were described (peripheral tissues and brain).

AB - The current paradigms of prevention and treatment are unable to curb obesity rates, which indicates the need to explore alternative therapeutic approaches. Obesity leads to several damages to the body and is an important risk factor for a number of other chronic diseases. Furthermore, despite the first alterations in obesity being observed and reported in peripheral tissues, studies indicate that obesity can also cause brain damage. Obesity leads to a chronic low-grade inflammatory state, and the therapeutic manipulation of inflammation can be explored. In this context, the use of n-3 PUFA (especially in the form of fish oil, rich in EPA and DHA) may be an interesting strategy, as this substance is known by its anti-inflammatory effect and numerous benefits to the body, such as reduction of TAG, cardiac arrhythmias, blood pressure and platelet aggregation, and has shown potential to help treat obesity. Thereby, the aim of this narrative review was to summarise the literature related to n-3 PUFA use in obesity treatment. First, the review provides a brief description of the obesity pathophysiology, including alterations that occur in peripheral tissues and at the central nervous system. In the sequence, we describe what are n-3 PUFA, their sources and their general effects. Finally, we explore the main topic linking obesity and n-3 PUFA. Animal and human studies were included and alterations on the whole organism were described (peripheral tissues and brain).

KW - Brain

KW - Inflammation

KW - n-3 PUFA

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=85044447594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044447594&partnerID=8YFLogxK

U2 - 10.1017/S0007114518000429

DO - 10.1017/S0007114518000429

M3 - Article

C2 - 29580307

AN - SCOPUS:85044447594

SP - 1

EP - 12

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

ER -